DEPRISA (Determination of Early Predictor of Ischemic Stroke: Adrenomedullin) 2 study

DEPRISA (Determination of Early Predictor of Ischemic Stroke: Adrenomedullin) 2 study - DEPRISA (Determination of Early Predictor of Ischemic Stroke: Adrenomedullin) 2 study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000052511

Enrollment

1000

Registered

2023-10-20

Start date

2023-10-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke, or stroke mimics

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The study included people aged 18 and older who had suspected strokes from the beginning of the study until March 31, 2025.

Exclusion criteria

Exclusion criteria: 1 Patients who declined to participate in this study by themselves or their family members. 2. Patients who were deemed unsuitable for participation in this study by the principal investigator or a collaborating researcher.

Design outcomes

Primary

Measure	Time frame
Plasma MR-proADM levels to discriminate between ischemic and hemorrhagic stroke	—

Secondary

Measure	Time frame
1) Association of plasma MR-proADM levels and diagnosis 2) Association between penumbra volumes and plasma MR-proADM levels in ischemic stroke 3) Association between collateral blood vessel grade and plasma MR-proADM levels 4) Association between plasma MR-proADM levels and prognosis	—

Countries

Japan

Contacts

Public ContactYuma Shiomi

National Cerebral and Cardiovascular Center Department of Neurology

shiomi.yuma@ncvc.go.jp0661701070

Outcome results